Geotrlchous stomatitis in the dental practice
https://doi.org/10.36377/1683-2981-2020-18-2-68-72
Abstract
About the Authors
L. V. VdovinaRussian Federation
Ph. D., Associate Professor, Department Propaedeutic Dentistry
Nizhniy Novgorod
N. V. Tiunova
Russian Federation
MD, Associate Professor, Department of Therapeutic Dentistry
Nizhniy Novgorod
S. M. Tolmacheva
Russian Federation
Ph. D., head ofTherapeutic Department of the Dental Office
Nizhniy Novgorod
I. N. Usmanova
Russian Federation
MD, Professor, Department of Therapeutic Dentistry
Ufa
References
1. Bagirova N. S., Dronova O. M., Volkova M. A. Dynamics of the frequency of fungal infections in patients with hemoblastoses. Bulletin of the N. N. Blokhin Russian research center. 1997; 8:25-28.
2. Bagirova N. S., Dronova O. M., Volkova M. A. Features of fungal infections in patients with hemoblastoses. Bulletin of the Blokhin cancer research center of the Russian Academy of medical Sciences. 1998; 9(3):43-49.
3. Bulieva N. B. Fungal infections as a complication of chemotherapy in patientswith hemoblastoses. MedicalCouncil. 2012; 1:50-56.
4. Rogacheva Yu. A., Popova M. O., Markova I. V. Invasive mycoses caused by rare pathogens in children with malignant tumors and nonmalignant diseases of hematopoietic and lymphatic tissue against the background of bone marrowtransplantation and antitumorchemotherapy. Pediatrics. Speranskymagazine; 2019; 98(1):28-35.
5. Shadrivova O. V., Did! S. N., Chudinovskikh Yu. A. and others. Invasive aspergillosis and mucormycosis in oncohematological patients. Oncohematology. 2018; 13(2): 39-47.
6. Kalinina 1.1., Petrov U. N., Goronkova O. V., etc. Infections caused by rare fungi in Hematology. Oncohematology. 2012; 7(4): 35-43.
7. Kornisheva V. G. Mycoses in HIV infection. Literature review. Problems ofmedical Mycology. 2013;4: 10-19.
8. LarionovV. B., D. A. Bykov. Candidiasis in hematologic malignancies. Oncohematology. 2007; 1: 62to 71.
9. Loess S. V., Lipnitsky A.V., Ochkurova O. M. fungal Infections of the digestive tract. Problems med. mycologies. 2004; 6(2): 19-23.
10. Tiunova N. V., Tolmacheva S. M., Egorova L. I., Zhdanova M. L. Features of professional hygiene in diseases of the oral mucosa. Dentistry foreveryone. 2015; 32: 19-21.
11. Klimko N. N., Kozlova Ya. I., Did! S. N., etc. Prevalence of severe and chronic mycotic diseases in the Russian Federation according to the LIFE program model. Problemsofmedical Mycology. 2014;16(1):3-9.
12. Proleskovskaya I. V., Litunovskaya L. G., Rutskaya E. A. Rare invasive mycoses in patients with oncogematological diseases. Medical news. 2013; 9: 37-41.
13. Rybakova M. A., Abugova Yu. G., Kalinina M. P. A Case of early diagnosis of rhinoorbitocerebral mucormycosis in a child with acute lymphoblastic leukemia. Russian journal of pediatric Hematology and Oncology. 2019; 6(S1).
14. Klyasova G. A., Okhmat V. A., Parovichnikova E. N. and others. Effectiveness of Posaconazole in the prevention of invasive mycoses in patients with acute myeloid leukemia. Medical Council. 2017; 14: 118-124.
15. Baran J.Jr., Muckatira B., Khatib R. Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital. Scand. J. Infec. Dis. 2001; 33:137-139.
16. Bodey G.P.Fungal infection in cancer patients - an overview. 1990; 2: 43.
17. Bodey G.P. Fungal infection in neutropenic patients: past achievements and future problems. In J. Klastersky (ed). Febrile neutropenia. 1997:63-74.
18. Bodey G.P., Mardani M., Hanna H.A. et al. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am. J. Med. 2002; 112: 380-385.
19. A. Vazquez-Gonzalez D., Macias B. et al. Oral geotrichosis: report of 12cases. J. Oral Sci. 2010; 52 (3): 477-483.
20. Edmond M.B., Wallace S.E., McClish D.K. et al. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin. Infect. Dis. 1999; 29: 239-244.
21. Gente S., Sohier D., Coton E. et al. Identification of Geotrichum candidum at the species and strain level: proposal for a standardized protocol. J. Ind. Microbiol. Biotechnol. 2006; 33(12): 1019-31.
22. Henrich T.J., Marty F.M., Milner D.A. Jr. et al. Disseminated Geotrichum candidum infection in a patient with relapsed acute myelogenous leukemia following allogeneic stem cell transplantation and reviewofthe literature. Transpl. Infect. Dis. 2009. 11 (5): 458-462.
23. Krcmery V., Barnes A.J. Non-albicans Candida spp causing fungaemia: pathogenicity and antifungal resistance. J. Hosp. Infect. 2002; 50:243-260.
24. MyintT., Dykhuizen M.J., McDonald C.H., Ribes J.A. Postoperative fungal endopthalmitis due to Geotrichum candidum. Med. Mycol. Case Rep. 2015; 1(10): 4-6. doi: 10.1016/j.mmcr.2015.11.001
25. Ostrosky-Zeichner L., Rex J.H., Pappas P. et al. Antifungal susceptibility survey of 2000 bloodstream Candida isolates in the United States. Antimicrob. AgentsChemother. 2013; 47: 3149-3154.
26. Pappas P.G., Rex J.H., Sobel J.D. etal. Guidelines for the treatment ofcandidiasis. Clin. Infect. Dis. 2004; 38: 161-189.
27. Pappas P.G., Rex J.H., Lee J. et al. A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. Clin. Infect. Dis. 2003; 37: 634643.
28. Periroth J., Choif B., Spellberg B. Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Division of Infectious Diseases & Department of Medicine, Harbor-University of California Los Angeles (UCLA) Medical Center and David Geffen School of Medicine at UCLA, California, USA. Medical Mycology. 2007; 45: 321-346.
29. Pfaller M.A., Jones R.N., Doem G.V. et al. Bloodstream infections due to Candida species: sentry antimicrobial surveillance program in North America and Latin America, 1997-1998. Antimicrob. Agents Chemotherra 2000; 44: 747-51.
30. Pfaller M.A., Diekema D.J., Jones R.N. et al. International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997through 1999 in the sentry antimicrobial surveillance program. J. Clin. Microbiol. 2001; 39:и3254- 3259.
31. Tsai M.H., Hsu J.F., Chu S.M. et al. Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of childrenwith candidemia.SciRep. 2017;7(1): 1083.
32. Wayne P.A. 8 NCCLS. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. NCCLS documentM27-A2. NCCLS. 2002; 17.
Review
For citations:
Vdovina L.V., Tiunova N.V., Tolmacheva S.M., Usmanova I.N. Geotrlchous stomatitis in the dental practice. Endodontics Today. 2020;18(2):68-72. (In Russ.) https://doi.org/10.36377/1683-2981-2020-18-2-68-72